ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
170 hedge funds and large institutions have $2.3B invested in Intra-Cellular Therapies Inc. in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 66 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
24% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 66
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
170
Holding in Top 10
2
Calls
$22.7M
Puts
$18.3M
Top Buyers
1 | +$72M | |
2 | +$39.6M | |
3 | +$11.5M | |
4 |
Invesco
Atlanta,
Georgia
|
+$9.53M |
5 |
BlackRock
New York
|
+$8.81M |
Top Sellers
1 | -$27M | |
2 | -$15.3M | |
3 | -$13.4M | |
4 |
SC
Samlyn Capital
New York
|
-$9.85M |
5 |
Norges Bank
Oslo,
Norway
|
-$8.36M |